FDA Approves Pneumococcal Disease Vaccine With Broader Protection
Links shared publicly online about this topic
FDA Approves Pneumococcal Disease Vaccine With Broader Protection
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2010 at 2:55 pm By:
FDA Approves Pneumococcal Disease Vaccine With Broader Protection The U.S. Food and Drug Administration approved Prev.. http://bit.ly/adkhzF
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
fda.gov — “The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.” View full resource at fda.gov
Most Recently Shared on February 24, 2010 at 6:31 pm By:
Len Leshin Physician, Doctor, and Pediatrician
FDA approves new #Pneumococcal Vaccine with Broader Protection for infants, toddlers http://bit.ly/9as7JB #pediatrics #Prevnar
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine
drugs.com — “Prevnar 13 (pneumococcal 13-valent conjugate vaccine) is used for prophylaxis of pneumococcal disease. Includes Prevnar 13 side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 26, 2010 at 1:03 am By:
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine - http://bit.ly/cx9k4D
Symposier - New Pneumococcal Vaccine for Children
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA has approved a new pneumococcal vaccine that provides broader protection for infants and young children ages six weeks through five years. The new vaccine, called Prevnar 13, is effective against 13 serotypes of the bacterium Streptococcus pneumoniae. It will replace Prevnar, which was effective against seven serotypes. Prevnar 13 is approved to prevent invasive pneumococcal disease, including bacterial meningitis and bacteremia, caused b” View full resource at symposier.com
Most Recently Shared on May 21, 2010 at 6:04 pm By:
FDA - New Pneumococcal Vaccine for Children. http://bit.ly/cML6lF
FDA weighs updated kids’ pneumococcal shot - Kids and parenting- msnbc.com
msnbc.msn.com — “The Food and Drug Administration is weighing whether to approve an updated version of Pfizer's best-selling anti-infection vaccine for children, despite company studies that failed to meet certain goals.” View full resource at msnbc.msn.com
Most Recently Shared on November 16, 2009 at 6:55 pm By:
msnbc.com - Health Health News
FDA weighs updated anti-infection shot for kids http://bit.ly/3JvqXL
Vaccine Offers More Coverage Against Pneumococcal Disease | The Kid's Doctor: Your Partner in Parenting
kidsdr.com — “New Prevnar vaccine offers more coverage against pneumococcal disease” View full resource at kidsdr.com
Most Recently Shared on April 7, 2010 at 12:46 pm By:
The Kid's Doctor Physician, Doctor, and Pediatrician
Dr. Sue's Daily Dose: new vaccine offers more coverage against Pneumococcal disease. http://tinyurl.com/ygkcsdt #moms #parenting #health
FDA OKs updated infection vaccine, Pfizer says - Kids and parenting- msnbc.com
msnbc.msn.com — “Pfizer said Wednesday the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for infants and children.” View full resource at msnbc.msn.com
Most Recently Shared on February 24, 2010 at 8:28 pm By:
FDA OKs updated infection vaccine, Pfizer says: Pfizer said Wednesday the Food and Drug Administration ha... http://bit.ly/abuGWL #children
PCV13 vaccine may have big effect among young children - Related Stories - AAP SmartBrief
smartbrief.com — “A CDC report said a recently approved broader pneumococcal vaccine could significantly reduce the rate of disease in young children. The FDA approved the PCV13 vaccine last month, and it covers pneumococcal strains that were responsible for 64% of pneumococcal cases in children under age 5 in 2007.” View full resource at smartbrief.com
Most Recently Shared on March 12, 2010 at 8:04 pm By:
Clara Song Pediatrician, Physician, and Doctor
PCV13 vaccine may have big effect among young children http://sbne.ws/r/42Wj
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
medical_tweets
-
Len Leshin
Husband, father to two boys, one with Down syndrome. Practicing pediatrician.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
